10th Parliament· 154 sittings on record · 30,475 speeches · latest 10 June 2026

The Hon. Hector Appuhamy

Samagi Jana Balawegaya· Puttalam· 10 October 2025 ·Debate: Private Members' Motion P.46/2025: National Drug Quality Assurance Laboratory

Public FinanceHealthcareCorruption & Governance Reform
AI summary generated by gpt-5.5

Hon. Hector Appuhamy seconded the motion and raised concerns about persistent weaknesses in Sri Lanka’s medicines regulatory system, particularly the composition and leadership of the NMRA. He argued that the NMRA Board lacks pharmaceutical regulatory expertise, questioned the Chairman’s private practice and alleged bias towards multinational companies over local manufacturers, and noted that promised upgrades to the NMRA laboratory had not been implemented. He said he would table more than 15 questions on allegations against the Chairman and called on the Government and Health Minister to decide on his position, warning that they would bear responsibility for future failures.

Verbatim record (translated)

Machine-translated from Sinhala / Tamil / English

¶ 01 Presiding Member, I second and add a few points. You know the longstanding issues in health services, especially medicines. For the first time in history, a Cabinet Minister went to jail—this shows the gravity. Medicines are life; safeguarding life is our collective duty, led by the President and Health Minister. Yet we see major gaps.

¶ 02 For a long time we have discussed the NMRA and its Chairman. Notably, there is no pharmacist/pharmaceutical scientist on its Board—no one with specialist medicine regulation expertise. While the doctors are competent in their field, do they have adequate regulatory knowledge? In many countries, medicine regulators are pharmacists and regulatory experts. Here it is not so.

¶ 03 Particularly regarding the Chairman—how has he handled local manufacturers? Given the economy, Government should not only support but strengthen and guide local pharma producers, addressing deficiencies. Instead, the NMRA leadership—especially Dr. Ananda—appears aligned with multinational interests. For the first time, an NMRA Chairman is providing private channeling services; how can someone engaged in private practice be the head of the regulator?

¶ 04 There seems to be a conspiracy: on one hand, local manufacturers are undermined; on the other, dealings favor multinationals. On the NMRA lab, the Chairman promised COPE a year ago to upgrade to international standards—but nothing has been done.

¶ 05 Serious allegations exist against the Chairman; I intend to table over 15 questions. We call on the Government and the Health Minister to make a decision regarding the NMRA Chairman; otherwise, responsibility for ensuing failures will rest with them.

Provenance

Source
Hansard, Friday, 10 October 2025 ·No. 22640 ·English daily/uncorrected Hansard
Page · column
not yet extracted — page/column anchors are not in the current dataset; the source PDF is the citable location.
Permalink
/lk/speeches/13977

Cite as: The Hon. Hector Appuhamy. 10th Parliament, Parliament of Sri Lanka. Hansard, 10 October 2025. No. 22640. Politick, https://staging.politick.io/lk/speeches/13977